Wood, Olivia R.
Schnall, Rebecca
Kay, Emma S.
Jia, Haomiao
Abua, Joseph A.
Nichols, Tyler K.
Olender, Susan A.
Mugavero, Michael J.
Batey, D. Scott
Funding for this research was provided by:
National Institute of Nursing Research (R01NR019758, R01NR019758, R01NR019758, R01NR019758, R01NR019758, R01NR019758, R01NR019758, R01NR019758, R01NR019758)
Article History
Received: 14 February 2023
Accepted: 5 April 2023
First Online: 24 May 2023
Declarations
:
: This study protocol was approved by the WIRB, Columbia University and University of Alabama at Birmingham IRBs. This protocol has been approved by the WCG Institutional Review Board (IRB Tracking Number: 20202675) with written informed consent. Study participants complete a written informed consent prior to participation in research activities. Current protocol version: December 20, 2022. Any modifications to the protocol are submitted to and approved by the IRB prior to implementation. Spontaneously reported adverse events and unintended effects of the trial are tracked by the study Principal Investigators and reported to the IRB. This study is monitored by a Data Safety and Monitoring Board (DSMB), the composition of which may be obtained from the study principal investigator. No criteria for discontinuing or modifying the intervention or trial stopping rules were defined for this study.
: Not applicable.
: The authors declare no competing interests.